AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015
Mar 5, 2015
30583_dirs_2015-03-05_40b81fe5-80d0-4780-a2c7-7e1ba8ed7a1e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-03-03
Reporting Person: Ajer Jeffrey Robert (SVP, Chief Commercial Of)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-03 | Common Stock | A | 10500 | — | Acquired | 42090 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-03-03 | Stock Option (right to buy) Common Stock | $108.36 | A | 23900 | Acquired | 2025-03-02 | Common Stock (23900) | Direct |
Footnotes
F1: Restricted stock units granted on March 3, 2015. Price not applicable.
F2: Option grant vests 6/48ths on September 3, 2015, and 1/48th on the 3rd day of every month thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19